Shirasaka, Y., Sager, J. E., Lutz, J. D., Davis, C., & Isoherranen, N. (2013). Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions. The American Society for Pharmacology and Experimental Therapeutics.
Chicago Style CitationShirasaka, Yoshiyuki, Jennifer E. Sager, Justin D. Lutz, Connie Davis, i Nina Isoherranen. Inhibition of CYP2C19 and CYP3A4 By Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions. The American Society for Pharmacology and Experimental Therapeutics, 2013.
Cita MLAShirasaka, Yoshiyuki, et al. Inhibition of CYP2C19 and CYP3A4 By Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions. The American Society for Pharmacology and Experimental Therapeutics, 2013.